Table: begin end state 1 11 cytoplasmic 12 40 transmembrane 41 47 non-cytoplasmic 48 71 transmembrane 72 82 cytoplasmic 83 104 transmembrane 105 115 non-cytoplasmic 116 138 transmembrane 139 157 cytoplasmic 158 177 transmembrane 178 183 non-cytoplasmic 184 203 transmembrane 204 233 cytoplasmic 234 258 transmembrane 259 272 non-cytoplasmic 273 293 transmembrane 294 299 cytoplasmic 300 319 transmembrane 320 329 non-cytoplasmic 330 353 transmembrane 354 364 cytoplasmic 365 388 transmembrane 389 393 non-cytoplasmic 394 415 transmembrane 416 434 cytoplasmic
Input: >Pf6N2E2_1184 LDSQGRERRKLVLAVSVGAALEWFDFTLFAIFSLQIAAAFFPASDPLMSLLASYLALAVG FVARPLGALLMGRYADRQGRKAALTLSIMLMGAGTLIIAVCPTYETIGWWAPLSVVVARI LQGVAAGGEIGGALAYLVETAPADRRALFASSQQVAQAGSFLLCGLSASLLSSALTPAQL DEWGWRVPYVFGLLVVVAGLKIRRSLEESEPLRRFLDNQDKHAMAGKGPSLRPYLPNLVM GVLIVVLWTVATQLINFIPTYASMVLELPRNKAYLGLVLVGLITLLCPLTALLSDRIGRY TVMLIGAVGVALCAYPGFVWLNNSPSLQTLIIFQCALAVLMVLYTGPAAAALAELFPVQV RALGVSLAYALSVTLFGSATPALITLIYRQSGDALAAAHWLFAAACLSAIPLAWVSLSKY RASATPALTAEHET
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server